Sleep duration, sleep quality and new markers of insulin resistance in obese subjects

Autori

  • Damiano Siligato UOC of Endocrinology, AOU Policlinico “G. Martino”, Messina
  • Annalisa Giandalia UOC of Endocrinology, AOU Policlinico “G. Martino”, Messina - Department of Human Pathology of Adults and Developmental Age "Gaetano Barresi", Messina
  • Giulia Basile UOC of Endocrinology, AOU Policlinico “G. Martino”, Messina
  • Oana Ruxandra Cotta UOC of Endocrinology, AOU Policlinico “G. Martino”, Messina
  • Letterio Giorgianni UOC of Endocrinology, AOU Policlinico “G. Martino”, Messina
  • Federica Galletta UOC of Endocrinology, AOU Policlinico “G. Martino”, Messina
  • Irene Aricò Sleep Medicine Center UOSD Neurophysiopathology and DISMOV AOU Policlinico “G. Martino”, Messina
  • Sakvatore Cannavò UOC of Endocrinology, AOU Policlinico “G. Martino”, Messina - Department of Human Pathology of Adults and Developmental Age "Gaetano Barresi", Messina

DOI:

https://doi.org/10.13129/1828-6550/APMB.113.1.2025.OS1

Abstract

Background: Sleep is an essential component of psychophysical well-being. Both insufficient duration and inadequate quality of sleep may increase the risk of diabetes mellitus, cardiovascular events and mortality. The relationship between short sleep duration and glucose disorders appears to be bidirectional. However, the link between duration, quality of sleep and new markers of insulin resistance (IR) in obesity is still unclear.

Aim: To evaluate sleep duration and quality in a group of overweight/obese subjects and their association with metabolic variables and IR markers.

Materials and methods: Anthropometric parameters, glycemic profile, biomarkers of IR were evaluated in adult patients with BMI >27 kg/m2 without severe OSA (Obstructive Sleep Apnea Syndrome). Sleep duration and quality were assessed using the PSQI (Pittsburgh Sleep Quality Index) questionnaire. IR was estimated using HOMA-IR, TyG index (Triglycerides-Glucose Index) and Tg/HDL ratio (triglycerides/HDL-cholesterol).

Results: The 84 subjects included in the analysis (BMI 36.14 kg/m2, waist circumference 110.42 cm) had a mean age of 54,65 years. The mean values of HOMA-IR (4.99±3.88), Tg/HDL (2.8±1.42) and TyG (4.74±0.25) were suggestive of a condition of insulin resistance. Nearly half of the patients (45%) had severe obesity and 84% had diabetes or IFG/IGT. The overall quality (total PSQI 7.63) and duration of sleep (5.76 hours) were not satisfactory and 59.5% of the patients had a total PSQI score >5, indicative of altered sleep quality.

When patients were divided according to the sleep quality, subjects with PSQI >5 (poor sleep quality) had higher values of BMI, waist circumference, and waist-to-height ratio, as compared to those with PSQI ≤5. Markers of IR, glycemic and lipid profile were similar in the two groups. Mean PSQI score and the percentage of subjects with poor sleep quality were significantly higher in patients with class II/III obesity, compared to those with BMI<35 Kg/m2 (9.38 vs 6.02 respectively, p<0.001 and 77% vs 43% p 0.04).

Conclusions: In this group of overweight/obese patients without severe OSA, we did not observe any association of sleep quality and duration with markers of IR. Sleep duration and quality were inadequate, especially in subjects with more severe degrees of obesity, suggesting an inverse relationship between sleep quality and visceral obesity.

Riferimenti bibliografici

1. Antza, C., Kostopoulos, G., Mostafa, S., Nirantharakumar, K., Tahrani, A. (2021). The links between sleep duration, obesity and type 2 diabetes mellitus. J Endocrinol, 13;252(2), 125-141.

2.Jiang, H., Zhang, H., Wen, Z., Yuan, J., Wang, H., Zhang, X. (2024). Association of sleep duration with obesity in older adults: A systematic review and meta-analysis. Geriatr Gerontol Int. 24(12), 1269-1282. doi: 10.1111/ggi.15004.

3. Lange, M.G., Neophytou, C., Cappuccio, F.P., Barber, T.M., Johnson, S., Chen, Y.F. (2024). Sex differences in the association between short sleep duration and obesity: A systematic-review and meta-analysis. Nutr Metab Cardiovasc Dis.;34(10):2227-2239. doi:10.1016/j.numecd.2024.06.008.

4. Wolk, R., Shamsuzzaman, A.S., Somers, V.K. (2003). Obesity, sleep apnea, and hypertension. Hypertension. 42:1067–74. doi: 10.1161/01.HYP.0000101686.98973.A3.

5.Leung, R.S., Bradley, T.D. (2001). Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med.;164:2147–65. doi: 10.1164/ajrccm.164.12.2107045.

6. Punjabi, N.M., Polotsky, V.Y. (2005). Disorders of glucose metabolism in sleep apnea. J Appl Physiol. 99:1998–2007. doi: 10.1152/japplphysiol.00695.2005.

7. Cappuccio, F.P., D'Elia, L., Strazzullo, P., et al. (2010) Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 33(5):585–92.

8. Åkerstedt, T., Ghilotti, F., Grotta, A., et al. (2019). Sleep duration and mortality-does weekend sleep matter? J Sleep Res. 28(1), e12712

9. Gottlieb, D.J., Punjabi, N.M., Newman, A.B. et al. (2005). Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med. 25;165(8), 863-7. doi: 10.1001/archinte.165.8.863.

10. Onyegbule, C.J., Muoghalu, C.G., Ofoegbu, C.C., Ezeorah, F. (2025). The Impact of Poor Sleep Quality on Cardiovascular Risk Factors and Quality of Life. Cureus. Jan 13;17(1), e77397.

11. Saee, H.A., Mohsen, A.H., Alqayem, A.T., Hasan, S.H., Hasan, M.M., Alzeera, H.A. (2024). Sleep Quality and Its Contributing Factors Among Patients With Obesity: A Cross-Sectional Study. Cureus. 19;16(11), e74038. doi: 10.7759/cureus.74038.

12. Friedewald, W.T., Levy, R.I., Fredrickson, D.S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem;18, 499-502
13. Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y.L., Castro, A.F. 3rd, Feldman, H.I., Kusek, J.W., Eggers, P., Van Lente, F., Greene, T., Coresh, J.; (2009). CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 5;150(9), 604-12

14. Guerrero-Romero, F., SimentaL-Mendía, L.E., González-Ortiz, M., et al. (2010). The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab.; 95(7), 3347–51

15. Giannini, C., Santoro, N. (2011). The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care. 34(8):1869–74.

16. Wang, L., Cong, H., Zhang, J., Hu, Y., Wei, A., Zhang, Y., Yang, H., Ren, L., Qi, W., Li, W. (2021). Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients with Coronary Artery Disease Treated with Statins. Front Cardiovasc Med. 21;8, 718604.

17. Buysse, D.J., Reynolds, C.F. 3rd, Monk, T.H., Berman, S.R., Kupfer, D.J. (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res.;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

18. Mollayeva, T., Thurairajah, P., Burton, K., Mollayeva, S., Shapiro, CM., Colantonio, A. (2016). The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis. Sleep Med Rev.; 25:52-73. doi: 10.1016/j.smrv.2015.01.009. Epub 2015 Feb 17.

19. Akashiba, T., Inoue, Y., Uchimura, N., Ohi, M., Kasai, T., Kawana, F., Sakurai, S., Takegami, M., Tachikawa, R., Tanigawa, T., Chiba, S., Chin, K., Tsuiki, S., Tonogi, M., Nakamura, H., Nakayama, T., Narui, K., Yagi, T., Yamauchi, M., Yamashiro, Y., Yoshida, M., Oga, T., Tomita, Y., Hamada, S., Murase, K., Mori, H., Wada, H., Uchiyama, M., Ogawa, H., Sato, K., Nakata, S., Mishima, K., Momomura, S.I. (2022). Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020. Respir Investig.; 60(1):3-32. doi: 10.1016/j.resinv.2021.08.010.

20. Lee, J.J., Sundar, K.M. (2021). Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome. Lung.; 199(2):87-101. doi: 10.1007/s00408-021-00426-w. Epub 2021 Mar 13.

21. St-Onge MP, Aggarwal B, Fernandez-Mendoza J, Johnson D, Kline CE, Knutson KL, Redeker N, Grandner MA; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research. Multidimensional Sleep Health: Definitions and Implications for Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2025 Apr 14:e000139.

22.Figorilli, M., Velluzzi, F., Redolfi, S. (2025). Obesity and sleep disorders: A bidirectional relationship. Nutr Metab Cardiovasc Dis. 15:104014. doi: 10.1016/j.numecd.2025.104014.

23. Lange, M.G., Neophytou, C., Cappuccio, F.P., Barber, T.M., Johnson, S., Chen, Y.F. (2024) Sex differences in the association between short sleep duration and obesity: A systematic-review and meta-analysis. Nutr Metab Cardiovasc Dis.; 34(10), 2227-2239.

St-Onge, M.P., Grandner, M.A., Brown, D., Conroy, M.B., Jean-Louis, G., Coons, M., Bhatt, D.L.; (2016). American Heart Association Obesity, Behavior Change, Diabetes, and Nutrition Committees of the Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association. Circulation. 1;134(18), e367-e386

Pubblicato

2025-06-06

Fascicolo

Sezione

ORIGINAL STUDY